Ryan Splittgerber
Belmont University(US)
Publications by Year
Research Areas
Melanoma and MAPK Pathways, NF-κB Signaling Pathways, Protein Degradation and Inhibitors, Computational Drug Discovery Methods, Cell Adhesion Molecules Research
Most-Cited Works
- → The ups and downs of peer review(2007)289 cited
- → Conditional ablation of Ikkb inhibits melanoma tumor development in mice(2010)97 cited
- → Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescence(2012)97 cited
- → RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors(2012)62 cited
- → NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway(2011)47 cited
- → Chemokines, macrophage inflammatory protein-2 and stromal cell-derived factor-1α, suppress amyloid β-induced neurotoxicity(2011)31 cited
- Snell's Clinical Neuroanatomy(2018)
- → Transcranial Doppler (TCD) and Trancranial Color-Coded Duplex Sonography (TCCS): Applied Neuroanatomy(2021)1 cited
- → Abstract 2889: NF-κB inducing kinase modulates melanoma tumorigenesis by regulating pro-survival factors through β-catenin(2011)1 cited
- → Data from RAF265 Inhibits the Growth of Advanced Human Melanoma Tumors(2023)